Nanopublications LDF server

Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB04865> ?p ?o ?g. }

• drugbank:DB04865 type drugbank_vocabulary:Drug assertion.
• drugbank:DB04865 label "Homoharringtonine [drugbank:DB04865]" assertion.
• drugbank:DB04865 seeAlso synribo-drug.htm assertion.
• drugbank:DB04865 seeAlso omacetaxine-injection.html assertion.
• drugbank:DB04865 seeAlso DB04865 assertion.
• drugbank:DB04865 description "Homoharringtonine, AKA HHT or omacetaxine mepesuccinate, is a cephalotaxine ester and protein synthesis inhibitor with established clinical activity as a single agent in hematological malignancies. Homoharringtonine is synthesized from cephalotaxine, which is an extract from the leaves of the plant, Cephalotaxus species. In October 2005, homoharringtonine received Orphan Drug designation from the EMEA for the treatment of chronic myeloid leukemia (CML). Then in March 2006, homoharringtonine received Orphan Drug status from the FDA for the treatment of CML. In November 2006, homoharringtonine, for the treatment of CML, was granted Fast Track designation by the FDA. Most recently, in October 2012, homoharringtonine was marketed under the brand name Synribo™ and FDA approved for patients who are intolerant and/or resistant to two or more tyrosine kinase inhibitors used to treat accelerated or chronic phase CML." assertion.
• drugbank:DB04865 identifier "drugbank:DB04865" assertion.
• drugbank:DB04865 title "Homoharringtonine" assertion.
• drugbank:DB04865 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB04865_DB08895 assertion.
• drugbank:DB04865 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00337_DB04865 assertion.
• drugbank:DB04865 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00108_DB04865 assertion.
• drugbank:DB04865 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01050_DB04865 assertion.
• drugbank:DB04865 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00945_DB04865 assertion.
• drugbank:DB04865 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00682_DB04865 assertion.
• drugbank:DB04865 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00864_DB04865 assertion.
• drugbank:DB04865 drugbank_vocabulary:food-interaction drugbank_resource:1d2b5b8e89d08e58c64887ef04aa1bed assertion.
• drugbank:DB04865 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:11075063 assertion.
• drugbank:DB04865 drugbank_vocabulary:x-pubchemcompound pubchem.compound:72332 assertion.
• drugbank:DB04865 drugbank_vocabulary:x-chemspider chemspider:65276 assertion.
• drugbank:DB04865 drugbank_vocabulary:x-cas cas:26833-87-4 assertion.
• drugbank:DB04865 drugbank_vocabulary:drugbank-id "DB04865" assertion.
• drugbank:DB04865 bio2rdf_vocabulary:x-identifiers.org DB04865 assertion.
• drugbank:DB04865 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04865" assertion.
• drugbank:DB04865 bio2rdf_vocabulary:namespace "drugbank" assertion.
• drugbank:DB04865 bio2rdf_vocabulary:identifier "DB04865" assertion.
• drugbank:DB04865 drugbank_vocabulary:x-wikipedia wikipedia:Omacetaxine_mepesuccinate assertion.
• drugbank:DB04865 drugbank_vocabulary:x-kegg kegg:D08956 assertion.
• drugbank:DB04865 drugbank_vocabulary:x-chebi chebi:71019 assertion.
• drugbank:DB04865 drugbank_vocabulary:x-atc atc:L01XX40 assertion.
• drugbank:DB04865 drugbank_vocabulary:x-ndc ndc:63459-177-14 assertion.